Wells Fargo’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.88M | Sell |
160,567
-4,631
| -3% | -$220K | ﹤0.01% | 2140 |
|
|
2025
Q4 | $6.17M | Buy |
165,198
+8,432
| +5% | +$342K | ﹤0.01% | 2472 |
|
|
2025
Q3 | $6.34M | Buy |
156,766
+12,138
| +8% | +$401K | ﹤0.01% | 2381 |
|
|
2025
Q2 | $3.69M | Sell |
144,628
-929
| -0.6% | -$20.3K | ﹤0.01% | 2701 |
|
|
2025
Q1 | $3.11M | Sell |
145,557
-4,121
| -3% | -$92.1K | ﹤0.01% | 2789 |
|
|
2024
Q4 | $3.14M | Buy |
149,678
+2,247
| +2% | +$52K | ﹤0.01% | 2821 |
|
|
2024
Q3 | $3.32M | Sell |
147,431
-2,879
| -2% | -$55.6K | ﹤0.01% | 2679 |
|
|
2024
Q2 | $2.52M | Buy |
150,310
+1,433
| +1% | +$23K | ﹤0.01% | 2799 |
|
|
2024
Q1 | $1.92M | Buy |
148,877
+35,559
| +31% | +$426K | ﹤0.01% | 3003 |
|
|
2023
Q4 | $1.31M | Sell |
113,318
-91,221
| -45% | -$1.03M | ﹤0.01% | 3243 |
|
|
2023
Q3 | $2.61M | Sell |
204,539
-1,806
| -0.9% | -$25.6K | ﹤0.01% | 2595 |
|
|
2023
Q2 | $2.83M | Buy |
206,345
+2,041
| +1% | +$29.2K | ﹤0.01% | 2618 |
|
|
2023
Q1 | $3.13M | Buy |
204,304
+8,867
| +5% | +$135K | ﹤0.01% | 2484 |
|
|
2022
Q4 | $2.62M | Sell |
195,437
-5,363
| -3% | -$71.9K | ﹤0.01% | 2567 |
|
|
2022
Q3 | $2.67M | Sell |
200,800
-20,582
| -9% | -$355K | ﹤0.01% | 2489 |
|
|
2022
Q2 | $4.24M | Sell |
221,382
-11,694
| -5% | -$221K | ﹤0.01% | 2216 |
|
|
2022
Q1 | $4.65M | Sell |
233,076
-53,273
| -19% | -$1.08M | ﹤0.01% | 2512 |
|
|
2021
Q4 | $5.85M | Sell |
286,349
-210,713
| -42% | -$4.5M | ﹤0.01% | 2410 |
|
|
2021
Q3 | $10.7M | Buy |
497,062
+37,937
| +8% | +$913K | ﹤0.01% | 2150 |
|
|
2021
Q2 | $13.3M | Buy |
459,125
+88,402
| +24% | +$2.39M | ﹤0.01% | 1997 |
|
|
2021
Q1 | $9.05M | Buy |
370,723
+148,541
| +67% | +$3.36M | ﹤0.01% | 2288 |
|
|
2020
Q4 | $4.32M | Buy |
222,182
+90,935
| +69% | +$1.67M | ﹤0.01% | 2887 |
|
|
2020
Q3 | $2.28M | Sell |
131,247
-3,910
| -3% | -$83.4K | ﹤0.01% | 3202 |
|
|
2020
Q2 | $3.55M | Sell |
135,157
-44,730
| -25% | -$1.11M | ﹤0.01% | 2788 |
|
|
2020
Q1 | $4.35M | Sell |
179,887
-103,975
| -37% | -$2.54M | ﹤0.01% | 2348 |
|
|
2019
Q4 | $7.05M | Buy |
283,862
+47,381
| +20% | +$1.1M | ﹤0.01% | 2271 |
|
|
2019
Q3 | $5.04M | Buy |
236,481
+38,483
| +19% | +$1.05M | ﹤0.01% | 2544 |
|
|
2019
Q2 | $6.29M | Sell |
197,998
-54,041
| -21% | -$1.69M | ﹤0.01% | 2366 |
|
|
2019
Q1 | $8.32M | Buy |
252,039
+101,282
| +67% | +$3.15M | ﹤0.01% | 2093 |
|
|
2018
Q4 | $4.85M | Buy |
150,757
+100,372
| +199% | +$3.79M | ﹤0.01% | 2468 |
|
|
2018
Q3 | $2.16M | Buy |
50,385
+10,827
| +27% | +$512K | ﹤0.01% | 3343 |
|
|
2018
Q2 | $1.82M | Sell |
39,558
-61,486
| -61% | -$2.72M | ﹤0.01% | 3522 |
|
|
2018
Q1 | $4.01M | Sell |
101,044
-1,419
| -1% | -$52.6K | ﹤0.01% | 2812 |
|
|
2017
Q4 | $3.43M | Buy |
102,463
+10,137
| +11% | +$360K | ﹤0.01% | 2921 |
|
|
2017
Q3 | $3.42M | Sell |
92,326
-21,790
| -19% | -$818K | ﹤0.01% | 2851 |
|
|
2017
Q2 | $4.23M | Sell |
114,116
-11,825
| -9% | -$386K | ﹤0.01% | 2585 |
|
|
2017
Q1 | $3.54M | Buy |
125,941
+932
| +0.7% | +$26.3K | ﹤0.01% | 2713 |
|
|
2016
Q4 | $3.66M | Buy |
125,009
+6,143
| +5% | +$168K | ﹤0.01% | 2655 |
|
|
2016
Q3 | $3.23M | Sell |
118,866
-1,508
| -1% | -$34.1K | ﹤0.01% | 2605 |
|
|
2016
Q2 | $2.25M | Buy |
120,374
+110,995
| +1,183% | +$2.31M | ﹤0.01% | 2882 |
|
|
2016
Q1 | $253K | Buy |
9,379
+982
| +12% | +$28.2K | ﹤0.01% | 4265 |
|
|
2015
Q4 | $253K | Buy |
8,397
+1,459
| +21% | +$46.8K | ﹤0.01% | 4312 |
|
|
2015
Q3 | $220K | Sell |
6,938
-5
| -0.1% | -$183 | ﹤0.01% | 4415 |
|
|
2015
Q2 | $271K | Buy |
6,943
+3,854
| +125% | +$133K | ﹤0.01% | 4436 |
|
|
2015
Q1 | $109K | Sell |
3,089
-1,713
| -36% | -$55.2K | ﹤0.01% | 4712 |
|
|
2014
Q4 | $152K | Buy |
4,802
+3,621
| +307% | +$100K | ﹤0.01% | 4568 |
|
|
2014
Q3 | $26K | Sell |
1,181
-20,462
| -95% | -$410K | ﹤0.01% | 5186 |
|
|
2014
Q2 | $475K | Buy |
+21,643
| New | +$411K | ﹤0.01% | 3946 |
|
Other funds holding PAHC
VCM
VPM
N
Wells Fargo's PAHC Position: Q1 2026 in Review
Wells Fargo reduced its Phibro Animal Health (PAHC) stake by 2.8% in Q1 2026, selling an estimated $220K and leaving 160,567 shares worth $8.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2140.
Wells Fargo first reported a position in PAHC in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.3M in Q2 2021. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Wells Fargo held 160,567 shares of Phibro Animal Health worth $8.88M as of Q1 2026.
- Wells Fargo sold 4,631 Phibro Animal Health shares in Q1 2026, an estimated $220K.
- Phibro Animal Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2140 holding.
- Wells Fargo first reported a position in Phibro Animal Health in Q2 2014 and has held it in 48 quarters since.
- Wells Fargo's Phibro Animal Health position peaked at $13.3M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.